New "Smart Chemo" Like Heat-Seeking Missile Against Cancer

There's a little-known biotech almost nobody knows about... Its stock trades at just $4 per share ...but the company recently won an FDA approval for its "Smart Chemo" drug for lymphoma. Our last "Smart Chemo" pick won FDA approval and soared from $5.30 to $28.89, a gain of 463% in 18 months.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

A message from our valued partners and today's trending news.

New "Smart Chemo" Like Heat-Seeking Missile Against Cancer - Ad There's a little-known biotech almost nobody knows about... Its stock trades at just $4 per share ...but the company recently won an FDA approval for its "Smart Chemo" drug for lymphoma. Our last "Smart Chemo" pick won FDA approval and soared from $5.30 to $28.89, a gain of 463% in 18 months. More Info ➔ Nvidia-Backed AI Startup Cohere Targets $5B Valuation In New Funding Round The Toronto-based firm, known for developing AI foundation models similar to those of OpenAI, has experienced significant revenue growth, jumping to an annualized rate of $22 million this month from $13 million in December. More Info ➔ Biden Out, _______ In? - Ad A new poll shows that two-thirds of Democrats want Biden to drop out of the 2024 race. See the new 2024 presidential election forecast from The Freeport Society. The truth will shock you. More Info ➔ Why Is Cancer Drug-Developer Nkarta Stock Trading Lower On Friday? Nkarta closed patient enrollment in NKX101 clinical trial, reallocating focus to lead program NKX019 for autoimmune disease. Recent expansion into autoimmune disease with FDA clearance for NKX019 in lupus nephritis signals company growth. Financially sound with $250.9 million in cash, expected to sustain operations through 2026. More Info ➔ Trump Reportedly Eyes Marco Rubio For VP In 2024 Presidential Bid But There Is A Hiccup Called The Constitution In the latest development surrounding the 2024 presidential race, former President Donald Trump is reportedly considering Sen. Marco Rubio (R-Fla.) as a potential vice presidential candidate. More Info ➔ Elon Musk's "Project Dojo" Is a Game-Changer - Ad Morgan Stanley predicts that Musk's latest act will boost Tesla's shares by 80% in the next 12 months. But if you want to profit from this development, you'll buy the firm that could see its sales explode by 829% as "Project Dojo" sweeps the nation. More Info ➔ Top 3 Financial Stocks That May Explode This Quarter The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies. More Info ➔ 2 crew members die during 'incident' on Holland America cruise ship FORT LAUDERDALE, Fla. (AP) — Two crew members on a Holland America cruise ship died during an “incident” in the ship's engineering space, the cruise line said. More Info ➔ Buy This A.I. Stock Before Elon's "A.I. Day" on May 16 - Ad Luke Lango is now recommending this little-known A.I. stock because it could supply Elon Musk with a critical piece of infrastructure for his new A.I. venture, something Luke is calling "Elon's A.I. 2.0". Once Elon reveals it on May 16, you may have missed the biggest gains. More Info ➔ NBC Divided: Staffers Stand Firm Against Featuring Top Republican As News Contributor NBCUniversal's news division is at odds over how to feature its latest news contributor, Ronna McDaniel, the former Chairwoman of the Republican National Committee (RNC). More Info ➔ Bitcoin In 'Danger Zone' Ahead Of Halving: Trader Warns Of Potential Price Drop Bitcoin has entered the 'danger zone' with a 4% drop and could face further decline before its halving event in 26 days, according to trader Rekt Capital. More Info ➔ This Is Growing Even Faster Than the Internet - Ad Imperium is set to grow from 1 million to over 2 BILLION users by 2026. But what is Imperium? It's our name for a groundbreaking technology that Elon Musk calls "amazing." And the company at the forefront of Imperium technology trades for just $10 a share. More Info ➔ The ELVIS Act: Tennessee's Bold Move To Protect Musicians In The AI Era When it comes to laws to keep artificial intelligence (AI) in check, it's now or never. More Info ➔ Initial public offerings scheduled to debut next week NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. More Info ➔ Energy agency announces $475M in funding for clean energy projects on mine land sites FRANKFORT, Ky. (AP) — The Biden administration pumped more money into projects Thursday, announcing up to $475 million in federal funding for projects in five states — including the political battleground states of Pennsylvania, Arizona and Nevada. More Info ➔ New Zealand slips into its second recession in 18 months as economy contracts WELLINGTON, New Zealand (AP) — New Zealand has entered its second recession in 18 months after the latest round of GDP figures confirmed its economy contracted in the last quarter of 2023. More Info ➔ Biden Vs. Trump: 2024 Election Front-Runners Tied In Latest Poll, Here Are The Top 5 Items Voters Say Are Most Important A head-to-head poll of voters sees Donald Trump and Joe Biden tied. Here's a look at the results and key items concerning voters. More Info ➔ Jim Cramer Would 'Rather Buy The Car Than The Stock' Of This Tesla Rival, But Says 'It's A Well-Run Company' Jim Cramer expressed his preference for the vehicle produced by Rivian Automotive Inc. over the company's stock. More Info ➔

Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault. 339-20 De Boers Dr., Toronto, ON M3J 0H1, 917.672.7040 © 2024 Musth | TrendAdvisor | All rights reserved. Unsubscribe